| Adipocyte hyperplasia and RMI1 in the treatment of obesity. | |
| | |
MedLine Citation:
|
PMID: 21199368 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The escalating prevalence of obesity is one of the most pressing health concerns of the modern era, yet existing medicines to combat this global pandemic are disappointingly limited in terms of safety and effectiveness. The inadequacy of currently available therapies for obesity has made new drug development crucial. In the past several decades, however, major progress has been achieved in understanding adipocyte hyperplasia associated with the pathogenesis of obesity, and consequently new potential targets for the medical treatment of obesity have been identified. We primarily review recent progress in the regulation of adipocyte hyperplasia as a novel emerging nontraditional approach. In this minireview, we focus on recQ-mediated genome instability 1 (RMI1), a recently identified novel molecular target for obesity treatment. RMI1-deficient mice have been found to be resistant to high-fat diet- and genetics-related obesity. Expression of this protein is regulated by E2F transcription factors, and recent studies have suggested that RMI1 plays an important role in the control of energy homeostasis during the development of obesity, with a mode of action based on the regulation of adipocyte hyperplasia. |
| | |
Authors:
|
Akira Suwa; Takeshi Kurama; Teruhiko Shimokawa |
Related Documents
:
|
20069998 - Weather or not: the importance of vitamin d status monitoring and supplementation. 8900828 - High serum concentrations of vitamin e and cholesterol and low mortality from ischaemic... 15531678 - Use of the deuterated-retinol-dilution technique to monitor the vitamin a status of nic... 20621498 - Fluctuations in sugar content are not determinant in explaining variations in vitamin c... 16901718 - Effects of dissolved oxygen on survival and immune responses of scallop (chlamys farrer... 8196748 - Availability of calcium from kilkeerai (amaranthus tricolor) and drumstick (moringa ole... |
Publication Detail:
|
Type: Journal Article Date: 2010-12-30 |
Journal Detail:
|
Title: The FEBS journal Volume: 278 ISSN: 1742-4658 ISO Abbreviation: FEBS J. Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-02-04 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101229646 Medline TA: FEBS J Country: England |
Other Details:
|
Languages: eng Pagination: 565-9 Citation Subset: IM |
Copyright Information:
|
© 2010 The Authors Journal compilation © 2010 FEBS. |
Affiliation:
|
Drug Discovery Research, Astellas Pharma Inc., Ibaraki, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hypothalamic malonyl-CoA and CPT1c in the treatment of obesity.
Next Document: Design of hairpin ribozyme variants with improved activity for poorly processed substrates.